Ryuta Muromoto

2.7k total citations
107 papers, 2.2k citations indexed

About

Ryuta Muromoto is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ryuta Muromoto has authored 107 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 51 papers in Oncology and 41 papers in Molecular Biology. Recurrent topics in Ryuta Muromoto's work include Cytokine Signaling Pathways and Interactions (39 papers), NF-κB Signaling Pathways (27 papers) and T-cell and B-cell Immunology (17 papers). Ryuta Muromoto is often cited by papers focused on Cytokine Signaling Pathways and Interactions (39 papers), NF-κB Signaling Pathways (27 papers) and T-cell and B-cell Immunology (17 papers). Ryuta Muromoto collaborates with scholars based in Japan, United States and Germany. Ryuta Muromoto's co-authors include Tadashi Matsuda, Yuichi Sekine, Kenji Oritani, Osamu Ikeda, Kazuya Shimoda, Kenji Sugiyama, Seiyu Imoto, Akihiko Yoshimura, Noriko Sato and Sumihito Togi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ryuta Muromoto

103 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuta Muromoto Japan 28 969 963 873 344 180 107 2.2k
Rainer Zenz Austria 16 1.3k 1.3× 733 0.8× 758 0.9× 370 1.1× 188 1.0× 20 2.6k
Steve Carbajal United States 24 1.2k 1.3× 803 0.8× 869 1.0× 420 1.2× 201 1.1× 37 2.5k
Maria Rosaria Ricciardi Italy 29 1.2k 1.3× 1.1k 1.2× 732 0.8× 352 1.0× 181 1.0× 83 2.8k
Anne Quillet‐Mary France 23 943 1.0× 735 0.8× 407 0.5× 159 0.5× 272 1.5× 54 1.9k
Xuesong Wu China 29 912 0.9× 787 0.8× 554 0.6× 328 1.0× 199 1.1× 90 2.2k
Manfred Jücker Germany 30 2.0k 2.0× 518 0.5× 904 1.0× 553 1.6× 451 2.5× 104 3.2k
Armin Neininger Germany 13 1.3k 1.4× 583 0.6× 517 0.6× 329 1.0× 118 0.7× 15 2.0k
Raj K. Batra United States 31 1.2k 1.2× 1.3k 1.4× 1.5k 1.7× 414 1.2× 89 0.5× 58 3.3k
Linda M. McAllister‐Lucas United States 25 1.3k 1.3× 1.0k 1.1× 518 0.6× 1.1k 3.1× 340 1.9× 46 2.5k
Masaaki Masuhara Japan 20 1.5k 1.6× 1.3k 1.3× 2.0k 2.3× 342 1.0× 161 0.9× 32 3.5k

Countries citing papers authored by Ryuta Muromoto

Since Specialization
Citations

This map shows the geographic impact of Ryuta Muromoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuta Muromoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuta Muromoto more than expected).

Fields of papers citing papers by Ryuta Muromoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuta Muromoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuta Muromoto. The network helps show where Ryuta Muromoto may publish in the future.

Co-authorship network of co-authors of Ryuta Muromoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuta Muromoto. A scholar is included among the top collaborators of Ryuta Muromoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuta Muromoto. Ryuta Muromoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamamoto, Kazuki, Ken Takashima, Ryuta Muromoto, et al.. (2025). A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. Oncogene. 44(50). 4846–4854.
3.
Ose, Toyoyuki, Yuichi Kitai, Ryuta Muromoto, et al.. (2023). STAP-2–Derived Peptide Suppresses TCR-Mediated Signals to Initiate Immune Responses. The Journal of Immunology. 211(5). 755–766. 2 indexed citations
4.
Muromoto, Ryuta, et al.. (2022). Regulation of NFKBIZ gene promoter activity by STAT3, C/EBPβ, and STAT1. Biochemical and Biophysical Research Communications. 613. 61–66. 8 indexed citations
5.
Kashiwakura, Jun‐ichi, Yuichi Sekine, Yuichi Kitai, et al.. (2022). STAP-2 Is a Novel Positive Regulator of TCR-Proximal Signals. The Journal of Immunology. 209(1). 57–68. 8 indexed citations
6.
Yamada, Shunsuke, Yuichi Kitai, Takashi Tadokoro, et al.. (2022). Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation. The Journal of Immunology. 209(1). 171–179. 11 indexed citations
7.
Muromoto, Ryuta, Kenji Oritani, & Tadashi Matsuda. (2022). Current understanding of the role of tyrosine kinase 2 signaling in immune responses. World Journal of Biological Chemistry. 13(1). 1–14. 32 indexed citations
8.
Kubota, Atsuhito, et al.. (2021). 5-Aminosalicylic Acid, A Weak Agonist for Aryl Hydrocarbon Receptor That Induces Splenic Regulatory T Cells. Pharmacology. 107(1-2). 28–34. 4 indexed citations
9.
Kitai, Yuichi, Jun‐ichi Kashiwakura, Ryuta Muromoto, et al.. (2021). Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival. Biochemical and Biophysical Research Communications. 556. 185–191. 8 indexed citations
10.
Muromoto, Ryuta, Tomohiro Matsumoto, Yuichi Kitai, et al.. (2020). The mechanism of Tyk2 deficiency-induced immunosuppression in mice involves robust IL-10 production in macrophages. Cytokine. 130. 155077–155077. 10 indexed citations
11.
Ichii, Michiko, Kenji Oritani, Hirohiko Shibayama, et al.. (2020). Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML. Oncogene. 39(34). 5601–5615. 13 indexed citations
12.
Muromoto, Ryuta, Yuichi Kitai, Jun‐ichi Kashiwakura, et al.. (2019). IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization. ImmunoHorizons. 3(5). 172–185. 18 indexed citations
13.
Muromoto, Ryuta, et al.. (2016). IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes. International Immunology. 28(9). 443–452. 58 indexed citations
14.
Ikeda, Osamu, Yuichi Sekine, Chikako Yamamoto, et al.. (2010). Involvement of STAP‐2 in Brk‐mediated phosphorylation and activation of STAT5 in breast cancer cells. Cancer Science. 102(4). 756–761. 30 indexed citations
15.
Sekine, Yuichi, Osamu Ikeda, Satoshi Tsuji, et al.. (2009). Signal-Transducing Adaptor Protein-2 Regulates Stromal Cell-Derived Factor-1α-Induced Chemotaxis in T Cells. The Journal of Immunology. 183(12). 7966–7974. 33 indexed citations
16.
Muromoto, Ryuta, Yuichi Sekine, Seiyu Imoto, et al.. (2008). BART is essential for nuclear retention of STAT3. International Immunology. 20(3). 395–403. 34 indexed citations
17.
Sekine, Yuichi, Satoshi Tsuji, Osamu Ikeda, et al.. (2007). Signal-Transducing Adaptor Protein-2 Regulates Integrin-Mediated T Cell Adhesion through Protein Degradation of Focal Adhesion Kinase. The Journal of Immunology. 179(4). 2397–2407. 53 indexed citations
18.
Sekine, Yuichi, Taro Yumioka, Tetsuya Yamamoto, et al.. (2006). Modulation of TLR4 Signaling by a Novel Adaptor Protein Signal-Transducing Adaptor Protein-2 in Macrophages. The Journal of Immunology. 176(1). 380–389. 83 indexed citations
19.
Shimoda, Kazuya, Akihiko Numata, Fumihiko Ishikawa, et al.. (2004). Tyrosine Kinase 2 Interacts with and Phosphorylates Receptor for Activated C Kinase-1, a WD Motif-Containing Protein. The Journal of Immunology. 173(2). 1151–1157. 10 indexed citations
20.
Muromoto, Ryuta, Kenji Sugiyama, Seiyu Imoto, et al.. (2004). Physical and Functional Interactions between Daxx and DNA Methyltransferase 1-Associated Protein, DMAP1. The Journal of Immunology. 172(5). 2985–2993. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rainer Zenz Breakdown of academic impact, for papers by Steve Carbajal Breakdown of academic impact, for papers by Maria Rosaria Ricciardi Breakdown of academic impact, for papers by Anne Quillet‐Mary Breakdown of academic impact, for papers by Xuesong Wu Breakdown of academic impact, for papers by Manfred Jücker Breakdown of academic impact, for papers by Armin Neininger Breakdown of academic impact, for papers by Raj K. Batra Breakdown of academic impact, for papers by Linda M. McAllister‐Lucas Breakdown of academic impact, for papers by Masaaki Masuhara
Rankless by CCL
2026